Correlation Between Sofwave Medical and ICL Israel

Can any of the company-specific risk be diversified away by investing in both Sofwave Medical and ICL Israel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sofwave Medical and ICL Israel into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sofwave Medical and ICL Israel Chemicals, you can compare the effects of market volatilities on Sofwave Medical and ICL Israel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sofwave Medical with a short position of ICL Israel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sofwave Medical and ICL Israel.

Diversification Opportunities for Sofwave Medical and ICL Israel

-0.47

Correlation Coefficient

Sofwave Medical  ICL Israel

Very good diversification

The 3 months correlation between Sofwave and ICL is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Sofwave Medical and ICL Israel Chemicals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ICL Israel Chemicals and Sofwave Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sofwave Medical are associated (or correlated) with ICL Israel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ICL Israel Chemicals has no effect on the direction of Sofwave Medical i.e., Sofwave Medical and ICL Israel go up and down completely randomly.

Pair Corralation between Sofwave Medical and ICL Israel

Assuming the 90 days trading horizon Sofwave Medical is expected to under-perform the ICL Israel. In addition to that, Sofwave Medical is 1.19 times more volatile than ICL Israel Chemicals. It trades about -0.07 of its total potential returns per unit of risk. ICL Israel Chemicals is currently generating about 0.11 per unit of volatility. If you would invest  158,324  in ICL Israel Chemicals on September 29, 2024 and sell it today you would earn a total of  19,676  from holding ICL Israel Chemicals or generate 12.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sofwave Medical  vs.  ICL Israel Chemicals

Sofwave Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sofwave Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

ICL Israel Chemicals

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in ICL Israel Chemicals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, ICL Israel sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sofwave Medical and ICL Israel

The main advantage of trading using opposite Sofwave Medical and ICL Israel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sofwave Medical position performs unexpectedly, ICL Israel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ICL Israel will offset losses from the drop in ICL Israel's long position.

The idea behind Sofwave Medical and ICL Israel Chemicals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.